Functional Spectrum of USP7 Pathogenic Variants in Hao-Fountain Syndrome: Insights into the Enzyme's Activity, Stability, and Allosteric Modulation
Emilie J. KorchakiD, Mona Sharafi, Isabella Jaen MaisonetiD, Andres F. Salazar‐Chaparro, Irina V. SemenovaiD, Hamza KhaniD, Alison O’NeiliD, Pilar CaroiD, Christian P. Schaaf, Sara J. BuhrlageiD, Irina BezsonovaiD
Abstract
Hao-Fountain syndrome is a rare neurodevelopmental disorder caused by mutations in the de-ubiquitinating enzyme USP7 (Ubiquitin Specific Protease 7). Due to the novelty of the disease and its poorly understood molecular mechanisms, treatments for the syndrome are currently lacking. This study examines the effects of 11 patient-derived variants located within the catalytic domain of USP7, focusing on their impact on the enzymes activity, thermodynamic stability, and substrate recognition. Our findings reveal a spectrum of functional consequences, ranging from complete inactivation to hyperactivation of USP7. Notably, we identify a specific subset of pathogenic variants whose catalytic activity can be significantly boosted using a novel allosteric activator. These results provide the first insight into USP7 malfunction in Hao-Fountain syndrome-linked variants and pave the way for improved prognostic approaches and targeted treatments in the future.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 1.50
- Field percentile
- top 18%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7)
Isabella Jaen Maisonet, Mona Sharafi, … Sara J. Buhrlage·Proceedings of the National Academy of SciencesPeer-reviewed·Oct 14, 2025
- Hao-Fountain Syndrome: 32 novel patients reveal new insights into the clinical spectrum
Moritz Claudius Wimmer, Heiko Brennenstuhl, … Christian Patrick Schaaf·Clinical GeneticsPeer-reviewed·Jan 14, 2024
- Activation Dynamics of Ubiquitin Specific Protease 7
G. J. Valles, N. Jaiswal, … I. Bezsonova·Proceedings of the National Academy of SciencesPeer-reviewed·May 21, 2025
- Hao-Fountain syndrome protein USP7 controls neuronal differentiation via BCOR-ncPRC1.1
Joyce Wolf van der Meer, Axelle Larue, … C. Peter Verrijzer·Genes & DevelopmentPeer-reviewed·Mar 1, 2025
- Molecular bases for USP48 cis-activity regulation and hyperactivation by Cushing's disease-associated mutations
Gai Ando, Yasutaka Tsujimoto, … Toshiaki Fukushima·bioRxiv·Dec 28, 2025
- High-throughput biochemical phenotyping of SHP2 variants reveals the molecular basis of diseases and allosteric drug inhibition
Albert A. Lee, Daniel Alexander Mokhtari, … Polly Morrell Fordyce·bioRxiv·Apr 2, 2026